Korea National Cancer Center
Korea National Cancer Center
Ilsan, South Korea1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| NB02 (Poseltinib) Combined Rituximab and Lenalidomide in R/R PCNSL | Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence | Recruiting | Phase 2 | 2024-12-17 | NCT06737250 |